LOWELL THOMAS HOLDEN Insider Trading $NBIO Nascent Biotech Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LOWELL THOMAS HOLDEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LOWELL THOMAS HOLDEN. LOWELL THOMAS HOLDEN is Chief Financial Officer in Skkynet Cloud Systems, Inc. ($SKKY) and CFO in Nascent Biotech Inc. ($NBIO).
LOWELL THOMAS HOLDEN in Nascent Biotech Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LOWELL THOMAS HOLDEN: CFO
Holdings: 9,558,077 shares
Current Value: $2,867,423
Latest Transaction: Apr 06 2021
$NBIO Market Capitalization: $6.97M
$NBIO Previous Close: $0.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of LOWELL THOMAS HOLDEN in Nascent Biotech Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 06 2021 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.06 | 810,000 | 49,410 | 10,368,077 | 9.6 M to 10.4 M (+8.47 %) |
| Apr 06 2021 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.06 | 1,000,000 | 60,000 | 9,558,077 | 8.6 M to 9.6 M (+11.68 %) |
| Jan 11 2021 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.05 | 1,442,000 | 66,476 | 8,558,077 | 7.1 M to 8.6 M (+20.26 %) |
| Jan 11 2021 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.07 | 127,970 | 8,958 | 7,116,077 | 7 M to 7.1 M (+1.83 %) |
| Jul 02 2020 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.10 | 534,000 | 53,400 | 6,988,107 | 6.5 M to 7 M (+8.27 %) |
| Jul 02 2020 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.10 | 2,901,890 | 290,189 | 6,454,107 | 3.6 M to 6.5 M (+81.69 %) |
| May 13 2020 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.10 | 1,000,000 | 100,000 | 3,562,217 | 2.6 M to 3.6 M (+39.03 %) |
| Apr 03 2020 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.13 | 265,160 | 34,471 | 20,000 | -245,160 to 20 K (-108.16 %) |
| Apr 03 2020 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.13 | 265,160 | 34,471 | 2,562,217 | 2.3 M to 2.6 M (+11.54 %) |
| Jan 06 2020 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | P | 0.17 | 5,000 | 825 | 2,292,057 | 2.3 M to 2.3 M (+0.22 %) |
| Jan 06 2020 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.10 | 56,700 | 5,670 | 2,287,057 | 2.2 M to 2.3 M (+2.54 %) |
| Jan 06 2020 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.10 | 830,000 | 83,000 | 2,230,357 | 1.4 M to 2.2 M (+59.27 %) |
| Oct 07 2019 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | P | 0.14 | 10,000 | 1,400 | 1,410,357 | 1.4 M to 1.4 M (+0.71 %) |
| Oct 07 2019 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.13 | 7,500 | 960 | 1,400,357 | 1.4 M to 1.4 M (+0.54 %) |
| Jul 08 2019 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.19 | 23,965 | 4,457 | 1,392,857 | 1.4 M to 1.4 M (+1.75 %) |
| Jun 06 2019 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Grant | A | 0.15 | 271,318 | 41,783 | 1,368,892 | 1.1 M to 1.4 M (+24.72 %) |
| Apr 17 2019 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.15 | 63,200 | 9,480 | 1,097,574 | 1 M to 1.1 M (+6.11 %) |
| Apr 17 2019 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.17 | 18,202 | 3,094 | 1,034,374 | 1 M to 1 M (+1.79 %) |
| Oct 02 2018 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.19 | 59,683 | 11,340 | 1,016,172 | 956.5 K to 1 M (+6.24 %) |
| Oct 02 2018 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.50 | 23,942 | 11,971 | 956,485 | 932.5 K to 956.5 K (+2.57 %) |
| Jun 05 2018 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.25 | 15,210 | 3,803 | 932,547 | 917.3 K to 932.5 K (+1.66 %) |
| Jun 05 2018 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.18 | 7,601 | 1,368 | 917,337 | 909.7 K to 917.3 K (+0.84 %) |
| Jun 05 2018 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.25 | 98,354 | 24,589 | 909,736 | 811.4 K to 909.7 K (+12.12 %) |
| Jun 05 2018 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.30 | 20,678 | 6,203 | 811,382 | 790.7 K to 811.4 K (+2.62 %) |
| Oct 10 2017 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.25 | 10,000 | 2,500 | 919,732 | 909.7 K to 919.7 K (+1.10 %) |
| Oct 10 2017 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.25 | 98,354 | 24,392 | 909,732 | 811.4 K to 909.7 K (+12.12 %) |
| Oct 10 2017 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.30 | 20,678 | 6,203 | 811,378 | 790.7 K to 811.4 K (+2.62 %) |
| Apr 04 2017 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.38 | 38,213 | 14,521 | 790,700 | 752.5 K to 790.7 K (+5.08 %) |
| Jan 09 2017 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.35 | 7,800 | 2,730 | 752,487 | 744.7 K to 752.5 K (+1.05 %) |
| Oct 13 2015 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | P | 1.45 | 617,346 | 895,152 | 717,346 | 100 K to 717.3 K (+617.35 %) |
Page: 1